AACR 2017



Proteintech is proud to support young cancer researchers by offering 2 x $1000 travel grants to attend the AACR annual meeting this April in Washington D.C.

Entry Deadline: March 6 2017
Terms and conditions apply.

Enter Here

AACR 2017

April 1-5, 2017, Washington DC

Application window open:
December 15, 2016 – February 16, 2017

Bio-Techne is proud to support researchers by offering 10 US$1000 travel grants to attend The American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C. in 2017. Apply by filling out the survey below.


Nanodiamonds and Cancer


The latest addition to the Proteintech blog investigates the use of nanoparticles as a new strategy of drug delivery. ‘Nano’ research has grown to be very popular amongst the scientific community. Up until now there have already been 84 publications regarding the use of nanodiamonds in cancer therapy and diagnosis.
See the full article at http://ow.ly/4n9DsJ.

HKU Scientists Effectively Suppress Tumour Growth by Converting Salmonella into YB1 Anaerobe Bacterium


A research team lead by Professor Jiandong Huang at HKU engineered the Salmonella into an anaerobe bacterium named YB1 which only survive and thrive in hypoxic regions inside solid tumours. YB1 can effectively inhibit the growth of tumours while being safe to normal tissues. The researchers hope that YB1 can be further developed into a tumour-targeting agent in the near future.

Professor Jiandong Huang at the School of Biomedical Sciences of Li Ka Shing Faculty of Medicine said, “Owing to the property that YB1 can survive in tumour, it can be viewed as a ‘guided missile’ to deliver destructive ‘warheads’ to the tumour tissue by means of delivering therapeutic proteins and drugs, resulting in tumour regression.”


Bin Yu, Mei Yang, Lei Shi, Yandan Yao, Qinqin Jiang, Xuefei Li, Lei-Han Tang, Bo-Jian Zheng, Kwok-Yung Yuen, David K. Smith, Erwei Song, and Jian-Dong Huang (2012) Explicit hypoxia targeting with tumor suppression by creating an “obligate” anaerobic Salmonella Typhimurium strain. Scientific Reports 2: 436.


Evaluation of metastatic burden and recovery of human metastatic cells from a mouse model


The spread of malignant cells in the body is an important topic of ‪‎cancer‬ ‪‎research‬ as metastases are the major cause of death in cancer-related diseases. From the latest MACS&more, Lorena Landuzzi et al. describe a method that allows the recovery and quantification of human metastatic cells in a mouse model and enables enrichment of these cells for in vitro analyses.


Dr. Olaf Hardt Lecture at Molecular Med Tri-Con 2016: Tumor Cell Isolation

Watch Dr. Olaf Hardt from Miltenyi Biotec R&D Oncology team describe a novel workflow for isolating pure ‪‎tumor‬ cell populations from primary tissue during last month’s ‪TriCon2016‬ in San Francisco

The Tumor Cell Isolation Kit, human enables the enrichment of human tumor cells from primary specimens using MACS® Cell Separation technology.  While depleting tumor associated cells such as lymphocyte subpopulations, fibroblasts, and endothelial cells in a fast and easy protocol, the tumor cells remain untouched, improving any downstream analysis.  Learn more http://goo.gl/Y2gZbO

A trip to New Orleans is not complete without a stop on Bourbon Street!

Bourbon Street

Are you heading to New Orleans for this years AACR Annual Meeting?
If so, you’re invited to join Proteintech for their bar crawl down the famous Bourbon Street!
Make sure you visit booth 749 to pick up your Proteintech cup. The cup entitles you to free drinks at each bar along with the chance to win an iPad in our prize draw.
For more information and to register for the event follow the link ow.ly/10jkAq